Groupe Hospitalier Pellegrin ( Site 0511)

Bordeaux, Gironde 33000

0 studies enrolling now · 2 studies all time

What they study most

Coronavirus Disease (COVID-19)

Studies at this site

• Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) — Completed
• Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001) — Stopped early